<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="BDX Shareholders Click Here: https://www.zlk.com/pslra-1/becton-dickinson-company-loss-form?prid=6170&wire=1
TLRY Shareholders Click Here: https://www.zlk.com/pslra-1/tilray-inc-loss-form?prid=6170&wire=1
TUFN Shareholders Click Here: https://www.zlk.com/pslra-1/tufin-software-technologies-ltd-loss-form?prid=6170&wire=1” data-reactid=”13″>BDX Shareholders Click Here: https://www.zlk.com/pslra-1/becton-dickinson-company-loss-form?prid=6170&wire=1
TLRY Shareholders Click Here: https://www.zlk.com/pslra-1/tilray-inc-loss-form?prid=6170&wire=1
TUFN Shareholders Click Here: https://www.zlk.com/pslra-1/tufin-software-technologies-ltd-loss-form?prid=6170&wire=1
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="* ADDITIONAL INFORMATION BELOW *” data-reactid=”14″>* ADDITIONAL INFORMATION BELOW *
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Becton Dickinson & Company (BDX)” data-reactid=”15″>Becton Dickinson & Company (BDX)
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="BDX Lawsuit on behalf of: investors who purchased November 5, 2019 – February 5, 2020
Lead Plaintiff Deadline : April 27, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/becton-dickinson-company-loss-form?prid=6170&wire=1” data-reactid=”16″>BDX Lawsuit on behalf of: investors who purchased November 5, 2019 – February 5, 2020
Lead Plaintiff Deadline : April 27, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/becton-dickinson-company-loss-form?prid=6170&wire=1
According to the filed complaint, during the class period, Becton Dickinson & Company made materially false and/or misleading statements and/or failed to disclose that: (1) certain of Becton’s Alaris infusion pumps experienced software errors and alarm prioritization issues; (2) as a result, the Company was investing in remediation efforts to address these product issues, rather than a software upgrade to “make enhancements;” (3) the Company was reasonably likely to face regulatory delays in connection with the software remediation; (4) as a result of the foregoing, Becton was reasonably likely to recall certain of its Alaris infusion pumps; and (5) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis.
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Tilray, Inc. (TLRY)” data-reactid=”18″>Tilray, Inc. (TLRY)
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="TLRY Lawsuit on behalf of: investors who purchased January 15, 2019 – March 2, 2020
Lead Plaintiff Deadline : May 5, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/tilray-inc-loss-form?prid=6170&wire=1” data-reactid=”19″>TLRY Lawsuit on behalf of: investors who purchased January 15, 2019 – March 2, 2020
Lead Plaintiff Deadline : May 5, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/tilray-inc-loss-form?prid=6170&wire=1
According to the filed complaint, during the class period, Tilray, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the purported advantages of the marketing and revenue sharing agreement with Authentic Brands Group (the “ABG Agreement”)were significantly overstated; (ii) the under performance of the ABG Agreement would foreseeably have a significant impact on the Company’s financial results; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Tufin Software Technologies Ltd. (TUFN)” data-reactid=”21″>Tufin Software Technologies Ltd. (TUFN)
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="TUFN Lawsuit on behalf of: investors who purchased securities pursuant and/or traceable to the registration statement and related prospectus issued in connection with Tufin’s April 2019 initial public offering
Lead Plaintiff Deadline : June 5, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/tufin-software-technologies-ltd-loss-form?prid=6170&wire=1” data-reactid=”22″>TUFN Lawsuit on behalf of: investors who purchased securities pursuant and/or traceable to the registration statement and related prospectus issued in connection with Tufin’s April 2019 initial public offering
Lead Plaintiff Deadline : June 5, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/tufin-software-technologies-ltd-loss-form?prid=6170&wire=1
According to the filed complaint, (1) Tufin’s customer relationships and growth metrics were overstated, particularly with respect to North America; (2) Tufin’s business was deteriorating, primarily in North America; (3) as a result, Tufin’s representations regarding its sustainable financial prospects were overly optimistic; and (4) as a result, the Offering Documents were materially false and/or misleading and failed to state information required to be stated therein.
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.” data-reactid=”24″>You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com” data-reactid=”26″>CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com
Add Comment